Pressure Rated: The MaxZero™ Extension Set with Needle-Free Connector(s) is for single use only. The MaxZero™ Extension Set with Needle-Free Connector(s) may be used for direct injection, intermittent infusion or aspiration. This set may be used with power injector procedures to a maximum pressure of 325 psi at a flow rate of 10mL per second.

Device Description

The MaxZero™ Extension Set with Needle-Free Connector(s) are intravascular extension sets intended for single patient use, including pediatrics (neonates, infants, children, adolescents) and immunocompromised patients, for direct injection, intermittent infusion continuous infusion or aspiration of drugs, blood and fluids, All MaxZero™ Extension Set with Needle-Free Connector(s) include the previously cleared zero reflux MZ1000 needleless Connector bonded to the extension set tubing. The MZ1000 needleless connector allows thorough and easy disinfection due to a solid, flat smooth surface and eliminates the risk of needle stick injuries. The MaxZero™ needleless connectors are sterile single patient devices that can be used for seven (7) days and 200 activations. All extension sets included in this submission are not made from natural rubber latex or DEHP.

AI/ML Overview

The provided document is a 510(k) summary for the MaxZero™ Extension Set with Needle-Free Connector(s). It details the device's technical characteristics, its substantial equivalence to a predicate device, and the non-clinical testing performed to support its safety and effectiveness.

Here is a breakdown of the requested information based on the provided text:

1. A table of acceptance criteria and the reported device performance

The document states: "All test results met their acceptance criteria and support that the MaxZero™ Extension Set with Needle-Free Connector(s) are appropriately designed for their intended use." However, specific numerical acceptance criteria and the exact reported performance results for each test are not provided in this summary. The summary only lists the types of tests performed.

Acceptance Criteria Category	Reported Device Performance
Functional Standards	Met acceptance criteria per ISO 594-1:1986, ISO 594-2:1998, ISO 8536-4:2010, ISO 8536-8:2004, ISO 8536-9:2004, ISO 8536-10:2004, and FDA Guidance for Intravascular Administration Sets.
Biocompatibility	Met acceptance criteria per ISO-10993-1:2009, ISO 10993-2:2006, ISO 10993-4:2002, ISO 10993-5:2009, ISO 10993-10:2010, ISO 10993-11:2006, ISO 10993-12:2012.
Sterilization & Shelf Life	Met acceptance criteria per ISO 11137-1:2006, ISO 11137-2:2006, ISO 11607:2003, ASTM F1980-07:2002, ASTM F1140:2000, ASTM D4169:1998, ASTM-F1929-98(04):1998.
Additional Performance Data	Met acceptance criteria for Microbial Ingress and Barrier testing, High-Pressure Testing, Air Water Interface Visibility, Set Internal Excess Pressure Testing, Clamps - Internal Excess Pressure and Tubing Open Fluid Path Testing, Bond Pull Testing, Priming Volume and Flow Rate Testing, and Harsh Infusates Testing.

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

The document does not explicitly state the sample sizes for the individual non-clinical tests. It refers to "design verification performance testing" and lists various standards and additional tests. The data provenance is not specified, but the submission is from CareFusion, Inc., located in San Diego, CA, USA. The testing would have been conducted by or for a US-based company, likely in the US or in a facility adhering to international standards for medical device testing. The data is prospective, as these are engineering and laboratory tests conducted to qualify the device.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

This section is not applicable as the document is discussing a non-clinical evaluation of a medical device (intravascular administration set) rather than diagnostic or imaging software requiring expert interpretation for ground truth establishment. The "ground truth" here is defined by engineering specifications and recognized performance standards.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

This section is not applicable for the same reason as point 3. Adjudication methods are typically used in clinical studies or evaluations of diagnostic systems where there might be disagreement in expert interpretations.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

There is no MRMC comparative effectiveness study mentioned. The submission is for a physical medical device (extension set) and not an AI-assisted diagnostic tool.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

This section is not applicable as the device is a physical medical device, not an algorithm or AI system.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

For this medical device, the "ground truth" is established through:

Engineering specifications and design requirements: The device must meet specific physical and performance parameters (e.g., pressure resistance, flow rates, bond strength).
Recognized consensus standards: The device performance is evaluated against international standards such as ISO and ASTM for medical devices, luer connectors, sterilization, packaging, and biocompatibility.
Biocompatibility guidelines: Specific ISO standards define acceptable biological responses and toxicity.
Regulatory guidance: Adherence to FDA guidance documents for intravascular administration sets.

8. The sample size for the training set

This section is not applicable as there is no machine learning or AI component requiring a training set. The device is a physical product.

9. How the ground truth for the training set was established

This section is not applicable as there is no machine learning or AI component requiring a training set and its associated ground truth establishment.

Summary

{0}------------------------------------------------

Image /page/0/Picture/2 description: The image is a seal for the Department of Health & Human Services - USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an abstract image of three human profiles facing to the right. The profiles are stacked on top of each other, with the top profile being the most prominent.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

July 19, 2017

CareFusion, Inc. % Mark Job Regulatory Technology Services. LLC 1394 25th Street North West Buffalo, Minnesota 55313 11021

Re: K171957

Trade/Device Name: MaxZero™ Extension Sets with Needleless Connector Regulation Number: 21 CFR 880.5440 Regulation Name: Intravascular Administration Set Regulatory Class: Class II Product Code: FPA Dated: June 28, 2017 Received: June 29, 2017

Dear Mr. Mark Job:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR

{1}------------------------------------------------

Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely.

Tara A. Ryan -S

for

Lori Wiggins Acting Director Division of Anesthesiology. General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

{2}------------------------------------------------

Indications for Use

510(k) Number (if known)

Device Name

MaxZero™ Extension Set with Needle-Free Connector(s)

Indications for Use (Describe)

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)	Over-The-Counter Use (21 CFR 801 Subpart C)
-------------------------------------------------------------------------------------------------	-------------------------------------------------------------------------------------

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

Image /page/3/Picture/0 description: The image shows the CareFusion logo. The logo consists of an orange circle with a white shield inside. The shield has a yellow accent on the top left corner. To the right of the circle is the text "CareFusion" in a dark gray sans-serif font.

510(k) K171957 Summary

Submitter Information

Submitter:	CareFusion, Inc.10020 Pacific Mesa Blvd.San Diego, CA 92121, USA
Contact Person:	Viviana Lai
Phone:	714-922-7679
Email:	Viviana.lai@carefusion.com
Date Prepared:	June 23, 2017

Subject Device Identification

Trade Name:	MaxZero™ Extension Set with Needle-Free Connector(s)
Common Name:	Intravascular Administration Set
Classification Name:	Intravascular Administration Set
Classification Panel:	General Hospital
Regulation Number:	21 CFR 880.5440
Requlatory Class:	Class II
Product Code:	FPA

Predicate Device Identification

Trade Name:	MaxZero™ Extension Sets with Needleless Connector
Manufacturer:	Carefusion, Inc.
510k Number:	K140831
510K Clearance Date:	April 15 2014

Reason for Submission

The objective of this submission is to introduce new components such as Needless Access Connector-Y (NAC-Y also known as Y-site) and Needless Access Connector-T (NAC-T also known as T-connector) connectors to the MaxZero™ Extension Set with Needle-Free Connector(s) product line configurations.

{4}------------------------------------------------

Image /page/4/Picture/0 description: The image shows the CareFusion logo. The logo consists of an orange circle with a white shield inside. The top left corner of the shield is yellow. To the right of the circle is the word "CareFusion" in gray.

Device Description

Indication for Use

Pressure Rated: The MaxZero™ Extension Set with Needle-Free Connector(s) is for single use only. The MaxZero™ Extension Set with Needle-Free Connector(s) may be used for direct injection, intermittent infusion, continuous infusion or aspiration. This set may be used with power injector procedures to a maximum pressure of 325 psi at a flow rate of 10mL per second.

Technological Characteristics

The information provided in the premarket notification demonstrates that the subject device, MaxZero™ Extension Set with Needle-Free Connector(s), is substantially equivalent to the legally marketed predicated devices. The subject device and the predicate device are intended to be used for the delivery and/or aspiration of fluids to/from an IV catheter in a hospital environment. The subject and the predicate devices are similar in physical properties, materials, and configuration. Each device includes connectors that allow for needleless access to the IV line during IV therapy eliminating the risk of needle injury. The subject device incorporates MaxZero™ Needleless Connector attached to IV tubing. Components of the subject devices are made of materials that are substantially equivalent to the predicate devices listed above and this submission includes comprehensive biocompatibility testing for all device materials included in this submission.

{5}------------------------------------------------

Image /page/5/Picture/0 description: The image shows the logo for CareFusion. The logo consists of an orange circle with a white shield inside, and the text "CareFusion" in gray. The shield has a yellow accent on the top left.

Substantial Equivalence Table

	MaxZero™ Extension Set withNeedle-Free Connector(s)(Subject Device)	CareFusion MaxZero™Extension Sets with NeedlelessConnector(Predicate device- K140831)
FDA Reg. Number	21 CFR 880.5440	21 CFR 880.5440
FDA RegulationName	Intravascular Administration Set	Intravascular Administration Set
FDA Class	Class II	Class II
FDA Product Code	FPA	FPA
Product Description	MaxZero™ Extension Set withNeedle-Free Connector(s) and thepredicate devices are sterile, singlepatient use, including pediatrics(neonates, infants, children,adolescents) andimmunocompromised patients fordirect inject, intermittent infusion,continuous infusion or aspiration ofdrugs, blood and fluids	MaxZero™ Extension Sets withNeedleless Connector and thepredicate devices are sterile, singlepatient use, including pediatricsand immunocompromised patientsfor direct inject, intermittentinfusion, continuous infusion oraspiration of drugs, blood andfluids
Intended Use	The MaxZero™ Extension Set withNeedle-Free Connector(s) is asterile single patient use deviceintended to be used for the deliveryand/or aspiration of fluids to/froman IV catheter.	The MaxZero™ Extension SetsWith Needleless Connector is asterile single patient use deviceintended to be used for thedelivery and/or aspiration of fluidsto/from an IV catheter.
Indications for Use	Pressure Rated: The MaxZero™Extension Set with Needle-FreeConnector(s) is for single use only.The MaxZero™ Extension Set withNeedle-Free Connector(s) may beused for direct injection,intermittent infusion, continuousinfusion or aspiration. This set maybe used with power injectorprocedures to a maximum pressureof 325 psi at a flow rate of 10mLper second.	Pressure Rated: The MaxZero™multi fuse extension set withneedleless connector(s) is forsingle use only. The extension setmay be used for direct injection,intermittent infusion, continuousinfusion or aspiration. This set maybe used with power injectorprocedures to a maximumpressure of 325 psi at a flow rateof 10mL per second.Non Pressure Rated: TheMaxZero™ multi fuse extension setwith needleless connector(s) is forsingle use only. The extension setmay be used for direct injection,intermittent infusion, continuousinfusion or aspiration.
Needless Connector	CareFusion MZ1000	CareFusion MZ1000
	MaxZero™ Extension Set withNeedle-Free Connector(s)(Subject Device)	CareFusion MaxZero™Extension Sets with NeedlelessConnector(Predicate device- K140831)
Device Components	MZ1000 Needleless Connector, PVCtubing with various lengths, slideclamps, male luer (spin lock),female luer (female wing adapter),NAC- Y connectors (Y-sites), NAC-Tconnectors (T-connectors)	MZ1000 Needleless Connector,PVC tubing with various length andID/OD, check valves, anti-siphonvalves, slide clamps, Y connectors,T-connectors, stopcocks, male spinlock and female wing adapter
Provided Sterile	Yes	Yes
Single Use	Yes	Yes

{6}------------------------------------------------

Image /page/6/Picture/0 description: The image shows the CareFusion logo. The logo consists of an orange circle with a white shield inside. The shield has a yellow accent on the top left corner. To the right of the circle is the word "CareFusion" in gray sans-serif font.

Explanation of Similarities and Differences technological Characteristics compared to Predicate Device

The Subject MaxZero™ Extension Set with Needle-Free Connector(s) have the following similarities to the predicate devices:

Same Intended Use and Indication for Use ●
Principle of operation ●
Device Design ●
Zero Reflux Needleless Connector ●
Designed to prevent microbial ingress ●
Needleless connector can be disinfected with 3 sec scrub with 70% IPA ●
Maximum clinical use of 7 days 200 activations for the needleless ● connector (single patient use)
. Non-hemolytic and Non-pyrogenic
Can be used with low power injectors with maximum of 325 psi & flow rate ● of 10ml/second (pressure rated sets)
. Not made with DEHP and not made with natural latex rubber
Safe for use in MRI environment ●
Sets can be used with harsh infusates ●

The following are technical characteristics differences between the subject and predicate devices:

. The subject device includes Needleless Access Connector-Y (NAC-Y also known as Y site) and Needless Access Connector-T (NAC-T also known as T connector) connectors that provide additional access ports.

{7}------------------------------------------------

Image /page/7/Picture/0 description: The image shows the logo for CareFusion. The logo consists of an orange circle with a white shield inside. The shield has a yellow accent on the top left corner. To the right of the circle is the word "CareFusion" in gray sans-serif font.

Discussion of Performance Data:

Non-Clinical Data

CareFusion performed design verification performance testing to verify, demonstrate and support the claim of substantial equivalence to the predicate devices. All test results met their acceptance criteria and support that the MaxZero™ Extension Set with Needle-Free Connector(s) are appropriately designed for their intended use.

Carefusion performed design verification performance testing according to the FDA recognized performance standards and guidelines.

. ISO 594-1:1986 Conical fittings with a 6% (luer) taper of syringes, needles and certain other medical equipment - Part 1: General requirements"
. ISO 594-2:1998 Conical fittings with 6%(luer) taper for syringes, needles, and certain other medical equipment - Part 2 Locking fittings"
. ISO 8536-4:2010 "Infusion equipment for medical use- Part 4: Infusion set for single use, gravity feed"
. ISO 8536-8:2004 "Infusion equipment for medical use – Part 8: Infusion equipment for medical use. Infusion equipment for use with pressure infusion apparatus"
. ISO 8536-9:2004 *Infusion equipment for medical use – Part 9: Fluid lines for single use with pressure infusion equipment"
. ISO 8536-10:2004 "Infusion equipment for medical use – Part 10: Accessories for fluid lines for single use with pressure infusion equipment"
. ISO 14971:2007 devices"
. Guidance for Industry and FDA Staff - Intravascular Administration Sets Premarket Notification Submission[510(k)], July 11,2008

The following additional performance data were collected.

. Microbial Ingress and Barrier testing
High-Pressure Testing
Air Water Interface Visibility
Set Internal Excess Pressure Testing .
. Clamps - Internal Excess Pressure and Tubing Open Fluid Path Testing
Bond Pull Testing ●
. Priming Volume and Flow Rate Testing
. Harsh Infusates Testing

{8}------------------------------------------------

Image /page/8/Picture/0 description: The image shows the CareFusion logo. The logo consists of an orange circle with a white shield inside. The shield has a yellow accent on the top left corner. To the right of the circle is the word "CareFusion" in a sans-serif font.

Biocompatibility

Biocompatibility assessments were conducted in accordance with ISO-10993-1:2009, "Biological evaluation of medical devices – part 1: Evaluation and testing within a risk management process," Carefusion performed the biocompatibility testing of the components and finish product according to the following parts of the ISO 10993 standard.

. ISO 10993-2:2006: "Biological evaluation of medical devices – part 2: Animal welfare requirements"
. ISO 10993-4:2002: "Biological evaluation of medical devices - part 4: Selection of tests for interactions with blood"
. ISO 10993-5:2009: "Biological evaluation of medical devices - part 5: Tests for in vitro cytotoxicity"
. ISO 10993-10:2010: "Biological evaluation of medical devices – part 10: Tests for irritation and delayed-type hypersensitivity"
. ISO 10993-11:2006: "Biological evaluation of medical devices – part 11: Test for systemic Toxicity"
. ISO 10993-12:2012: "Biological evaluation of medical devices - part 12: Sample preparation and reference materials"

Sterilization and Shelf life

The subject device, MaxZero™ Extension Set with Needle-Free Connector(s), is radiation sterilized and the shelf life data supports a shelf life claim of 3 years. Sterilization and shelf life testing were completed according to the following FDA recognized quidelines:

. ISO 11137-1:2006 "Sterilization of health care products - Radiation- Part 1: Requirements for development, validation and routine control of a sterilization process for medical devices"
ISO 11137-2:2006 "Sterilization of health care products Radiation Part 2 -● Establishing the sterilization dose"
. ISO 11607:2003 "Packaging for terminally sterilized medical devices"
ASTM F1980-07: 2002 "Standard Guide for Accelerated Aging of Sterile . Barrier Systems for Medical Devices"
ASTM F1140:2000 Standard Test Method for Burst Testing of Flexible Package Seals Using Internal Air Pressurization within Restraining Plates"
ASTM D4169: 1998 " Standard Practice for Performance Testing of Shipping . Containers and Systems"
ASTM-F1929-98(04): 1998 "Standard Test Method for Detecting Seal Leaks in ● Porous Medical Packaging by Dye Penetration"

{9}------------------------------------------------

Image /page/9/Picture/0 description: The image shows the CareFusion logo. The logo consists of an orange circle with a white shield inside. The shield has a yellow accent on the top left corner. To the right of the circle is the word "CareFusion" in gray sans-serif font.

Clinical Data

There is no clinical data included in this submission.

Conclusion

The device met the acceptance criteria for all functional, microbial ingress, sterility, biocompatibility and other performance criteria. The conclusions drawn from the nonclinical tests that demonstrate that the new device is as safe, as effective, and performs as well as the predicate device.

Regulation Number and Section

§ 880.5440 Intravascular administration set.

(a)
Identification. An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.(b)
Classification. Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.